Trovafloxacin-induced acute hepatitis

Clinical Infectious Diseases

Volumn 30, Issue 2, 2000, Pages 400-401

  Lucena, M Isabel ^a,d   Andrade, Raúl J ^a   Rodrigo, Luis ^b   Salmerón, Javier ^c   Alvarez, Arancha ^b   Lopez Garrido, M J ^c   Camargo, Raquel ^a   Alcantára, Ramiro ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d Facultad de Medicina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEMAFLOXACIN; TROVAFLOXACIN;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; FLU LIKE SYNDROME; HEMOLYSIS; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; LIVER BIOPSY; LOBAR PNEUMONIA; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

ACUTE DISEASE; ADULT; AGED; ANTI-INFECTIVE AGENTS; BIOPSY, NEEDLE; FLUOROQUINOLONES; HEPATITIS, TOXIC; HUMANS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NAPHTHYRIDINES; PNEUMONIA, PNEUMOCOCCAL; PROGNOSIS; RESPIRATORY TRACT INFECTIONS;

EID: 0034012255     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313680     Document Type: Article

References (4)

1. 1. Garey KW, Amsden GW. Trovafloxacin: an overview. Pharmacotherapy 1999; 19:21-34.
2. 2. Lucena MI, Andrade RJ, Sanchez-Martinez H, Perez-Serrano JM, Gomez-Outes A. Norfloxacin-induced cholestatic jaundice. Am J Gastroenterol 1998;93:2309-11.
3. 3. European Agency for the Evaluation of Medicinal Products. Public statement on trovafloxacin/alatrofloxacin: recommendation to suspend the marketing authorisation in the European Union. London, 15 June 1999.
4. 4. Blum MD, Graham DJ. Temafloxacin syndrome: review of 95 cases. Clin Infect Dis 1994; 18:946-50.